Targeting the $5 BILLION Soft Tissue Repair Market

Chitogenx is in the regulatory lead for regenerative products + signs MOU with major Medical Institute

Free
Message: SmallCap 60: Ortho Regenerative Tech. (ORTH: CSE) (ORTIF: OTCQB) Proprietary RESTORE Technology

Share
New Message
Please login to post a reply